Author/Creator: Heidegger, Simon - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Heidegger, Simon

1. Card9 controls Dectin‐1‐induced T‐cell cytotoxicity and tumor growth in mice. Issue 5 (10th April 2017)

Authors:: Haas, Tobias; Heidegger, Simon; Wintges, Alexander; Bscheider, Michael; Bek, Sarah; Fischer, Julius C.; Eisenkolb, Gabriel; Schmickl, Martina; Spoerl, Silvia; Peschel, Christian; Poeck, Hendrik; Ruland, Jürgen
Journal:: European journal of immunology
Issue:: Volume 47:Issue 5(2017)
Page Start:: 872
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Combined Treatment With Pembrolizumab and Allogenic BK Virus-Specific T Cells in Progressive Multifocal Leukoencephalopathy: A Case Report. Issue 5 (September 2021)

Authors:: Wicklein, Rebecca; Heidegger, Simon; Verbeek, Mareike; Eiz-Vesper, Britta; Maecker-Kolhoff, Britta; Kirschke, Jan Stefan; Page, Agata; Korn, Thomas; Hemmer, Bernhard; Deschauer, Marcus
Journal:: Neurology
Issue:: Volume 8:Issue 5(2021)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Experimental investigation of skin toxicity after immune checkpoint inhibition in combination with radiation therapy. Issue 2 (12th August 2022)

Authors:: Lansink Rotgerink, Laura; Felchle, Hannah; Feuchtinger, Annette; Nefzger, Sophie M; Walther, Caroline N; Gissibl, Julia; Steiger, Katja; Schmid, Thomas E; Heidegger, Simon; Combs, Stephanie E; Fischer, Julius C
Journal:: Journal of pathology
Issue:: Volume 258:Issue 2(2022)
Page Start:: 189
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Immune response to functionalized mesoporous silica nanoparticles for targeted drug delivery. Issue 2 (11th December 2015)

Authors:: Heidegger, Simon; Gößl, Dorothée; Schmidt, Alexandra; Niedermayer, Stefan; Argyo, Christian; Endres, Stefan; Bein, Thomas; Bourquin, Carole
Journal:: Nanoscale
Issue:: Volume 8:Issue 2(2016)
Page Start:: 938
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Targeting intrinsic RIG-I signaling turns melanoma cells into type I interferon-releasing cellular antitumor vaccines. (3rd April 2019)

Authors:: Bek, Sarah; Stritzke, Florian; Wintges, Alexander; Nedelko, Tatiana; Böhmer, Daniel F.R.; Fischer, Julius C.; Haas, Tobias; Poeck, Hendrik; Heidegger, Simon
Journal:: Oncoimmunology
Issue:: Volume 8:Number 4(2019)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Tumor cell‐intrinsic RIG‐I signaling governs synergistic effects of immunogenic cancer therapies and checkpoint inhibitors in mice. Issue 6 (5th April 2021)

Authors:: Poeck, Hendrik; Wintges, Alexander; Dahl, Sarah; Bassermann, Florian; Haas, Tobias; Heidegger, Simon
Journal:: European journal of immunology
Issue:: Volume 51:Issue 6(2021)
Page Start:: 1531
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗